GENMAB A/S (GMAB) Form 6-K — Jun 15, 2026
Genmab A/S filed a Form 6-K disclosing the issuance of employee warrants under its existing compensation programs. On June 11, 2026, the Board of Directors granted warrants to subscribe for 15,494 ordinary shares to employees of the Company and its subsidiaries. The warrants carry an exercise price of DKK 1,616.50 per share, which is set at or above the market price on the date of issue. These grants are part of a series of routine employee incentive issuances authorized by the General Meeting in 2017, 2019, 2021, and 2024.
Key figures
- Offering Price
- DKK 1,616.50
- Shares Offered
- 15494
- Currency
- DKK
- Nominal value per share
- DKK 1
- Total warrants granted june 2026
- 15494
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.